[Possibility for the favorable influencing of convalescence following gynecologic radiotherapy].
D000731:Androstanes / Q000627:therapeutic use*; D000737:Androstenols / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use*; D003036:Cobalt Isotopes; D003289:Convalescence; D003553:Cystine / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D005833:Genital Neoplasms, Female / Q000532:radiotherapy / Q000534:rehabilitation*; D006801:Humans; D010051:Ovarian Neoplasms / Q000532:radiotherapy / Q000534:rehabilitation; D010205:Pantothenic Acid / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D011867:Radioisotope Teletherapy; D013831:Thiamine / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy / Q000534:rehabilitation; D014594:Uterine Neoplasms / Q000532:radiotherapy / Q000534:rehabilitation; D014801:Vitamin A / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000627:therapeutic use*
D000731:Androstanes; D000737:Androstenols; D003036:Cobalt Isotopes; D014801:Vitamin A; D014803:Vitamin B Complex; D010205:Pantothenic Acid; D003553:Cystine; D011736:Pyridoxine; D014805:Vitamin B 12; D001205:Ascorbic Acid; D013831:Thiamine
Eine Möglichkeit zur günstigen Beeinflussung der Rekonvaleszenz nach gynäkologischer Strahlentherapie.